AAAAAA

   
Results: 1-9 |
Results: 9

Authors: VALLE J CLEMONS M BRETTI S DOUGALL M ANDERSON H SCARFFE JH
Citation: J. Valle et al., ETOPOSIDE, DOXORUBICIN (ADRIAMYCIN) AND CISPLATIN CHEMOTHERAPY (EAP) FOR ADVANCED GASTRIC CANCER - RESULTS OF A PHASE-II STUDY AND FINAL REVIEW, GI cancer, 2(3), 1998, pp. 207-213

Authors: VALLE J CLEMONS M HAYES S FALLOWFIELD L HOWELL A
Citation: J. Valle et al., CONTRACEPTIVE USE BY WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER, Breast, 7(3), 1998, pp. 143-149

Authors: CLEMONS M LEAHY M VALLE J JAYSON G RANSON M HAYES S HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - STUDIES EXCLUDING TAXANES, European journal of cancer, 33(13), 1997, pp. 2171-2182

Authors: CLEMONS M LEAHY M VALLE J JAYSON G RANSON M HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - THE TAXANES, European journal of cancer, 33(13), 1997, pp. 2183-2193

Authors: BEALES ILP CLEMONS M KONG WM
Citation: Ilp. Beales et al., MISOPROSTOL-ASSOCIATED PLATELET-AGGREGATION DYSFUNCTION AND INCREASEDGASTROINTESTINAL BLOOD-LOSS, European journal of gastroenterology & hepatology, 9(1), 1997, pp. 91-92

Authors: VALLE J CLEMONS M HAYES S FALLOWFIELD L HOWELL A
Citation: J. Valle et al., SEXUALITY IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 8(6), 1997, pp. 616-617

Authors: CLEMONS M VALLE J HARRIS M WEAVER A ELLENBOGEN S HOWELL A
Citation: M. Clemons et al., CITROBACTER-FREUNDII AND FATAL NEUTROPENIC ENTEROCOLITIS FOLLOWING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 8(4), 1997, pp. 405-405

Authors: CLEMONS M REGNARD C APPLETON T
Citation: M. Clemons et al., ALERTNESS, COGNITION AND MORPHINE IN PATIENTS WITH ADVANCED CANCER, Cancer treatment reviews, 22(6), 1996, pp. 451-468

Authors: BETTICHER DC LEE SM MORRIS C CLEMONS M THATCHER N
Citation: Dc. Betticher et al., DACARBAZINE AND INTERFERON-ALPHA 2A IN ADVANCED MALIGNANT-MELANOMA - HIGH RESPONSE RATE AND PROLONGATION OF RESPONSE DURATION OCCUR IN DIFFERENT PATIENT SUBPOPULATIONS, Melanoma research, 5(4), 1995, pp. 277-282
Risultati: 1-9 |